ChengDu ShengNuo BiotecLtd Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Yongjun Wen
Algemeen directeur
CN¥748.8k
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | no data |
Eigendom CEO | 0.2% |
Management gemiddelde ambtstermijn | geen gegevens |
Gemiddelde ambtstermijn bestuur | geen gegevens |
Recente managementupdates
Recent updates
ChengDu ShengNuo BiotecLtd (SHSE:688117) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 04ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117) Stocks Shoot Up 32% But Its P/E Still Looks Reasonable
Aug 26A Look At The Fair Value Of ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117)
Jun 19ChengDu ShengNuo BiotecLtd (SHSE:688117) Strong Profits May Be Masking Some Underlying Issues
Apr 29There's Reason For Concern Over ChengDu ShengNuo Biotec Co.,Ltd.'s (SHSE:688117) Massive 27% Price Jump
Mar 04CEO
Yongjun Wen (59 yo)
no data
Tenure
CN¥748,800
Compensatie
Mr. Yongjun Wen serves as Chairman and General Manager at ChengDu ShengNuo Biotec Co., Ltd. he serves as a Consultant at Roton Capital Management Co., Ltd. Mr. Wen has experience in peptide drug CDMO proje...